Porsolt & Metris Sign a Co-Marketing Agreement
News Nov 26, 2009
Porsolt and Partners Pharmacology (Porsolt) and Metris have announced that they have entered into a global co-marketing agreement to promote preclinical screening services using Laboras , a non-invasive technology for automatic and comprehensive in vivo behavioral characterization of drug candidates.
Under this alliance, Porsolt will offer CRO services utilizing the in vivo screening platform to its clients. The Laboras system enables the measurement of multiple behavioral pharmacodynamic endpoints in a single experiment utilizing a high throughput non-invasive system.
Dr. Martine Lemaire, Senior Director - Commercial & Business Development of Porsolt said, “We are thrilled by the synergy between Porsolt’s long-established and recognized expertise in behavioral pharmacology and the high-quality, proven utility of the Laboras innovative technology system.
This partnership has formed in response to the needs expressed by Porsolt’s clients for increased information on drug-like molecules earlier in the drug discovery process. It fits obviously with our strategy to constantly deliver superior quality scientific solutions tailored to our customer’s need.”
New Partnership to Provide Bioanalytical and DMPK ServicesNews
Concept Life Sciences, the integrated drug discovery, development and analytical services company, and Alderley Analytical, bioanalytical Contract Research Organisation (CRO), today announced they have signed a partnership agreement to provide high-value bioanalytical and DMPK study services.
Arrow Poison Potential Male Birth ControlNews
Women have many options for oral contraceptives that are safe, effective and reversible, but despite decades of research, men have none. Now, scientists report a rat study that shows they finally have a good lead for a male birth control pill. It's based on ouabain, a plant extract that African warriors and hunters traditionally used as a heart-stopping poison on their arrows.READ MORE